151 related articles for article (PubMed ID: 15201662)
1. Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection.
Kuyvenhoven JP; Verspaget HW; Gao Q; Ringers J; Smit VT; Lamers CB; van Hoek B
Transplantation; 2004 Jun; 77(11):1646-52. PubMed ID: 15201662
[TBL] [Abstract][Full Text] [Related]
2. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases 2 and 9 in donor liver, cirrhotic liver, and acute rejection after human liver transplantation.
Kirimlioglu H; Kirimlioglu V; Yilmaz S
Transplant Proc; 2008 Dec; 40(10):3574-7. PubMed ID: 19100442
[TBL] [Abstract][Full Text] [Related]
4. Acute cellular rejection is associated with matrix metalloproteinase-2 genotype chimerism after orthotopic liver transplantation.
Korkmaz KS; Ten Hove WR; de Rooij BJ; van Hoek B; van der Reijden JJ; Coenraad MJ; Dubbeld J; Verspaget HW
Transplant Proc; 2013 Mar; 45(2):558-63. PubMed ID: 23498792
[TBL] [Abstract][Full Text] [Related]
5. Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation.
Kuyvenhoven JP; Ringers J; Verspaget HW; Lamers CB; van Hoek B
Transplant Proc; 2003 Dec; 35(8):2967-9. PubMed ID: 14697951
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.
Kuyvenhoven JP; van Hoek B; Blom E; van Duijn W; Hanemaaijer R; Verheijen JH; Lamers CB; Verspaget HW
Thromb Haemost; 2003 Apr; 89(4):718-25. PubMed ID: 12669127
[TBL] [Abstract][Full Text] [Related]
7. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
Pei F; Zheng J; Du J; Zhong HH; Yang JP
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation.
Ten Hove WR; Korkmaz KS; op den Dries S; de Rooij BJ; van Hoek B; Porte RJ; van der Reijden JJ; Coenraad MJ; Dubbeld J; Hommes DW; Verspaget HW
Liver Int; 2011 Sep; 31(8):1110-7. PubMed ID: 21745270
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease.
Murawaki Y; Yamada S; Ikuta Y; Kawasaki H
J Hepatol; 1999 Jun; 30(6):1090-8. PubMed ID: 10406188
[TBL] [Abstract][Full Text] [Related]
11. Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers.
Kuo WH; Chou FP; Lu SC; Chu SC; Hsieh YS
Clin Chim Acta; 2000 Apr; 294(1-2):157-68. PubMed ID: 10727681
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.
Yeh HC; Lin SM; Chen MF; Pan TL; Wang PW; Yeh CT
Hepatogastroenterology; 2010; 57(97):98-102. PubMed ID: 20422881
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C.
Reif S; Somech R; Brazovski E; Reich R; Belson A; Konikoff FM; Kessler A
Digestion; 2005; 71(2):124-30. PubMed ID: 15785038
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Badra G; Lotfy M; El-Refaie A; Obada M; Abdelmonem E; Kandeel S; Fathy A
Acta Microbiol Immunol Hung; 2010 Mar; 57(1):29-42. PubMed ID: 20350877
[TBL] [Abstract][Full Text] [Related]
15. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy.
Rodrigo E; López-Hoyos M; Escallada R; Fernández-Fresnedo G; Ruiz JC; Piñera C; Cotorruelo JG; Zubimendi JA; de Francisco AL; Arias M
Nephrol Dial Transplant; 2000 Dec; 15(12):2041-5. PubMed ID: 11096152
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
Ermolli M; Schumacher M; Lods N; Hammoud M; Marti HP
Transpl Immunol; 2003; 11(2):137-45. PubMed ID: 12799196
[TBL] [Abstract][Full Text] [Related]
18. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma.
Kamel L; Nessim I; Abd-el-Hady A; Ghali A; Ismail A
J Egypt Soc Parasitol; 2005 Dec; 35(3):875-90. PubMed ID: 16333896
[TBL] [Abstract][Full Text] [Related]
20. Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
Murawaki Y; Ikuta Y; Okamoto K; Koda M; Kawasaki H
J Hepatol; 1999 Sep; 31(3):474-81. PubMed ID: 10488707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
